Women SHINE Intervention for HIV/AIDS
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a program called Women SHINE, designed to assist women with HIV/AIDS who have experienced violence and struggle with medication adherence. The study will compare two groups: one receiving Women SHINE support and the other receiving basic self-care resources (control group). Women with HIV who have experienced violence as adults and find it difficult to consistently take their medication might be suitable candidates. The goal is to determine if Women SHINE can improve medication adherence and emotional health. As an unphased trial, this study offers participants a unique opportunity to contribute to research that could enhance support systems for women facing similar challenges.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. However, since participants must be currently prescribed ART (HIV medication), it seems you should continue taking it.
What prior data suggests that the Women SHINE intervention is safe?
Research shows that trauma-informed programs like Women SHINE are generally well-received. These programs provide peer support and education to assist women with HIV/AIDS who have experienced interpersonal violence.
Previous studies on similar programs have shown improvements in mental health and social support without major safety issues. Participants often report feeling better and developing stronger coping skills. Significant negative effects from these programs have not been reported.
Overall, evidence suggests that the Women SHINE program is safe, enhancing emotional and social support without introducing physical or medical risks.12345Why are researchers excited about this trial?
Researchers are excited about the Women SHINE intervention because it offers a holistic and peer-supported approach to addressing HIV/AIDS in women, setting it apart from traditional medical treatments. Unlike standard care, which often focuses solely on medication, Women SHINE includes a combination of video-based one-on-one peer navigation and weekly psycho-education support group sessions. This method emphasizes mental health, interpersonal violence, and substance use alongside HIV care, providing a comprehensive support system. The integration of peer navigators who share similar experiences with participants adds a unique layer of relatability and support, potentially leading to improved health outcomes and empowerment for women living with HIV/AIDS.
What evidence suggests that this trial's treatments could be effective for women living with HIV/AIDS?
Research has shown that the Women SHINE program, a treatment in this trial, might assist women with HIV/AIDS who have experienced violence and struggle with medication adherence. Women in similar programs have improved their adherence to antiretroviral therapy (ART), crucial for controlling the virus. The Women SHINE intervention provides personalized support from peer supporters and group therapy sessions, enhancing emotional health and coping skills. This support can significantly help women maintain medication consistency and improve overall health. Early signs suggest this approach may improve both mental health and medication habits.16789
Who Is on the Research Team?
Jamila K Stockman, PhD, MPH
Principal Investigator
University of California, San Diego
Are You a Good Fit for This Trial?
This trial is for cisgender women over 18 living with HIV/AIDS who have experienced interpersonal violence as adults and are not fully adherent to their antiretroviral therapy (ART). Participants must speak English or Spanish, have internet access, and cannot be involved in another adherence intervention.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Women SHINE intervention arm receives a four-month program including video-based peer navigation support, 7 weekly psychoeducation support group sessions, and access to a static website with resources.
Control
Control arm receives one 60-minute group session on self-care and well-being and access to a static website with resources.
Follow-up
Participants are monitored for improvements in ART adherence, PTSD symptoms, and emotion regulation at 4-, 8-, and 12-months post-randomization.
What Are the Treatments Tested in This Trial?
Interventions
- Control
- Women SHINE
Trial Overview
The study compares the Women SHINE web-based peer support program against a control group. The Women SHINE group receives one-on-one sessions, check-ins, support groups with therapists, and resource access. The control gets a single self-care session and similar resources.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Women SHINE consists of a four-month intervention that includes video-based one-on-one peer navigation and 7 weekly psycho-education support group sessions co-facilitated by a licensed clinical therapist (LCT) and peer navigator (PN). 180 women will be enrolled in the Women SHINE intervention and will remain in their assigned psycho-education support group sessions with the same members over the course of the intervention.
Women assigned to the control arm (n=180) will receive one 60-minute group session facilitated by the licensed clinical therapist (LCT) on self-care and well-being as it relates to HIV, interpersonal violence, trauma, adverse mental health, and substance use. During this session, women will be provided with resources to HIV care, interpersonal violence, trauma, mental health, and substance use, through a static website created for Women SHINE. The content will include: 1) names and locations of clinics and organizations, services provided, and contact information; 2) links to support websites and hotlines and 3) testimonials from WLHA.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator
Published Research Related to This Trial
Citations
Women SHINE: Addressing Syndemics and HIV Among ...
In the US, women living with HIV/AIDS (WLHA) are less likely to be adherent to antiretroviral therapy (ART) and virally suppressed compared to men living with ...
Women SHINE Intervention for HIV/AIDS
This trial is for cisgender women over 18 living with HIV/AIDS who have experienced interpersonal violence as adults and are not fully adherent to their ...
Women SHINE: Addressing Syndemics and HIV Among ...
In the US, women living with HIV/AIDS (WLHA) are less likely to be adherent to antiretroviral therapy (ART) and virally suppressed compared to ...
Women SHINE
Women SHINE is a randomized controlled trial that aims to improve antiretroviral therapy (ART) adherence among women living with HIV/AIDS (WLHA)
About - Women SHINE
Women SHINE is a web-based peer navigation intervention to help cisgender women living with HIV/AIDS improve their HIV care and mental well-being.
LinkPositively: A Trauma-Informed Peer Navigation and Social ...
Abstract. In the U.S., Black women living with HIV/AIDS (WLHA) are affected disproportionately by interpersonal violence, which often co-occurs with adverse ...
A Trauma-Informed HIV Intervention (LinkPositively) to ...
The substance use, violence, and HIV/AIDS syndemic is the overlapping and synergistic intersection of these conditions [ ...
A Trauma-Informed HIV Intervention (LinkPositively) to ...
The substance use, violence, and HIV/AIDS syndemic is the overlapping and synergistic intersection of these conditions [5]; in addition, mental ...
Exploring the Impact of an Integrated Trauma-Informed HIV ...
An Expressive Therapy Group Disclosure Intervention for Women Living with HIV Improves Social Support, Self-Efficacy, and the Safety and Quality of ...
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.